Microsoft To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Key takeaways
- Analysts are reshuffling targets across tech, pharma, and retail, with Microsoft and Moderna seeing notable upgrades while others face cuts.
- Microsoft target $610 (+11%)
- Moderna target $80 (+33%)
- Carmax target $48 (+45%)
What happened
Top Wall Street analysts have revised their price targets for a dozen U.S. stocks, with notable upgrades for Microsoft Corp (MSFT) and Moderna Inc and downgrades for companies such as Accelerant Holdings and Jack Henry & Associates.
Why it matters
These adjustments signal shifting expectations for earnings growth and valuation multiples, which can influence short‑term trading activity and longer‑term investment theses.
Short-term and longer-term
Short-term. Short‑term traders should watch Microsoft’s 10‑day moving average for a potential breakout after the $610 target, while Moderna’s 20‑day trend could signal a rally if the $80 target is breached.
Longer-term. Over the next few months, the upgraded valuations for Microsoft and Moderna could justify a higher equity allocation, whereas the cuts to Accelerant and Jack Henry suggest a reassessment of their growth prospects.